Figure 9. . Treatment.

Each bar represents treatment utilization within a given study cohort. Text adjacent to each bar notes the specific liver-direct treatment used, as described by study authors.

^†Treatment categories considered in analysis were transplant, resection, ablation, or none.

^‡Most invasive treatment listed if patient underwent multiple procedures.

^§Sorafenib was not considered in analysis.

^¶Initial treatment.

^#Data from subset of patients in which sorafenib and radiation were separated were used for this figure.

^††Treatments not mutually exclusive.

NIS: National Inpatient Sample; SEER: Surveillance, Epidemiology and End Results; TACE: Transarterial chemoembolization; TARE: Transarterial radioembolization; UHC: University Health Consortium; UNOS: United Network on Organ Sharing.

Sources: Cauble, 2013 [55]; Ha, 2016 [77]; Sanoff, 2017 [69]; Sanyal, 2010 [20]; Serper, 2017 [79]; Shaya, 2014 [70]; Sobotka, 2019 [72].